Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Histone Deacetylase (HDAC) Inhibitor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Histone Deacetylase (HDAC) Inhibitormarket, defines the market attractiveness level of Histone Deacetylase (HDAC) Inhibitor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Histone Deacetylase (HDAC) Inhibitor industry, describes the types of Histone Deacetylase (HDAC) Inhibitor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Histone Deacetylase (HDAC) Inhibitor market and the development prospects and opportunities of Histone Deacetylase (HDAC) Inhibitor industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Histone Deacetylase (HDAC) Inhibitor market in Chapter 13.
By Player:
Envivo Pharmaceuticals
Celleron Therapeutics
Novartis
CrystalGenomics
Acetylon Pharmaceuticals
Celgene
By Type:
Hydroxamates
Cyclic Peptides
Aliphatic Acids
Benzamides
By End-User:
Cancer
Central Nervous System Disorders
Other Diseases
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Histone Deacetylase (HDAC) Inhibitor Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Histone Deacetylase (HDAC) Inhibitor Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Histone Deacetylase (HDAC) Inhibitor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Histone Deacetylase (HDAC) Inhibitor Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Histone Deacetylase (HDAC) Inhibitor Market Analysis and Outlook to 2022
-
7.1 Global Histone Deacetylase (HDAC) Inhibitor Consumption (2017-2022)
-
7.2 United States Histone Deacetylase (HDAC) Inhibitor Consumption (2017-2022)
-
7.3 Europe Histone Deacetylase (HDAC) Inhibitor Consumption (2017-2022)
-
7.4 China Histone Deacetylase (HDAC) Inhibitor Consumption (2017-2022)
-
7.5 Japan Histone Deacetylase (HDAC) Inhibitor Consumption (2017-2022)
-
7.6 India Histone Deacetylase (HDAC) Inhibitor Consumption (2017-2022)
-
7.7 South Korea Histone Deacetylase (HDAC) Inhibitor Consumption (2017-2022)
8 Region and Country-wise Histone Deacetylase (HDAC) Inhibitor Market Analysis and Outlook to 2028
-
8.1 Global Histone Deacetylase (HDAC) Inhibitor Consumption Forecast (2022-2028)
-
8.2 United States Histone Deacetylase (HDAC) Inhibitor Consumption Forecast (2022-2028)
-
8.3 Europe Histone Deacetylase (HDAC) Inhibitor Consumption Forecast (2022-2028)
-
8.4 China Histone Deacetylase (HDAC) Inhibitor Consumption Forecast (2022-2028)
-
8.5 Japan Histone Deacetylase (HDAC) Inhibitor Consumption Forecast (2022-2028)
-
8.6 India Histone Deacetylase (HDAC) Inhibitor Consumption Forecast (2022-2028)
-
8.7 South Korea Histone Deacetylase (HDAC) Inhibitor Consumption Forecast (2022-2028)
9 Global Histone Deacetylase (HDAC) Inhibitor Market Outlook by Types and Applications to 2022
-
9.1 Global Histone Deacetylase (HDAC) Inhibitor Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Hydroxamates Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Cyclic Peptides Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Aliphatic Acids Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Benzamides Consumption and Growth Rate (2017-2022)
-
9.2 Global Histone Deacetylase (HDAC) Inhibitor Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Central Nervous System Disorders Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Diseases Consumption and Growth Rate (2017-2022)
10 Global Histone Deacetylase (HDAC) Inhibitor Market Outlook by Types and Applications to 2028
-
10.1 Global Histone Deacetylase (HDAC) Inhibitor Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Hydroxamates Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Cyclic Peptides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Aliphatic Acids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Benzamides Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Histone Deacetylase (HDAC) Inhibitor Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Central Nervous System Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Diseases Consumption Forecast and Growth Rate (2022-2028)
11 Global Histone Deacetylase (HDAC) Inhibitor Import and Export Analysis (Top 5 Countries)
-
11.1 Global Histone Deacetylase (HDAC) Inhibitor Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Histone Deacetylase (HDAC) Inhibitor Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Histone Deacetylase (HDAC) Inhibitor Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Histone Deacetylase (HDAC) Inhibitor Market Competitive Analysis
-
14.1 Envivo Pharmaceuticals
-
14.1.1 Envivo Pharmaceuticals Company Details
-
14.1.2 Envivo Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Envivo Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Product and Service
-
14.2 Celleron Therapeutics
-
14.2.1 Celleron Therapeutics Company Details
-
14.2.2 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitor Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Histone Deacetylase (HDAC) Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Histone Deacetylase (HDAC) Inhibitor Product and Service
-
14.4 CrystalGenomics
-
14.4.1 CrystalGenomics Company Details
-
14.4.2 CrystalGenomics Histone Deacetylase (HDAC) Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitor Product and Service
-
14.5 Acetylon Pharmaceuticals
-
14.5.1 Acetylon Pharmaceuticals Company Details
-
14.5.2 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Product and Service
-
14.6 Celgene
-
14.6.1 Celgene Company Details
-
14.6.2 Celgene Histone Deacetylase (HDAC) Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Celgene Histone Deacetylase (HDAC) Inhibitor Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Histone Deacetylase (HDAC) Inhibitor
-
Figure Histone Deacetylase (HDAC) Inhibitor Picture
-
Table Global Histone Deacetylase (HDAC) Inhibitor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Histone Deacetylase (HDAC) Inhibitor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Histone Deacetylase (HDAC) Inhibitor Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Histone Deacetylase (HDAC) Inhibitor Consumption by Country (2017-2022)
-
Figure United States Histone Deacetylase (HDAC) Inhibitor Consumption and Growth Rate (2017-2022)
-
Table Europe Histone Deacetylase (HDAC) Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure China Histone Deacetylase (HDAC) Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Japan Histone Deacetylase (HDAC) Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure India Histone Deacetylase (HDAC) Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure South Korea Histone Deacetylase (HDAC) Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Histone Deacetylase (HDAC) Inhibitor Consumption Forecast by Country (2022-2028)
-
Figure United States Histone Deacetylase (HDAC) Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Histone Deacetylase (HDAC) Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Histone Deacetylase (HDAC) Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Histone Deacetylase (HDAC) Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Histone Deacetylase (HDAC) Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Histone Deacetylase (HDAC) Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hydroxamates Consumption and Growth Rate (2017-2022)
-
Figure Global Cyclic Peptides Consumption and Growth Rate (2017-2022)
-
Figure Global Aliphatic Acids Consumption and Growth Rate (2017-2022)
-
Figure Global Benzamides Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Central Nervous System Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Other Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Hydroxamates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cyclic Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aliphatic Acids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Benzamides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Central Nervous System Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Histone Deacetylase (HDAC) Inhibitor Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Histone Deacetylase (HDAC) Inhibitor Export by Region (Top 5 Countries) (2017-2028)
-
Table Envivo Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Envivo Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Envivo Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Product and Service
-
Table Celleron Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitor Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Histone Deacetylase (HDAC) Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Histone Deacetylase (HDAC) Inhibitor Product and Service
-
Table CrystalGenomics (Foundation Year, Company Profile and etc.)
-
Table CrystalGenomics Histone Deacetylase (HDAC) Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table CrystalGenomics Histone Deacetylase (HDAC) Inhibitor Product and Service
-
Table Acetylon Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Histone Deacetylase (HDAC) Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Histone Deacetylase (HDAC) Inhibitor Product and Service
-
